| BMC Cardiovascular Disorders | |
| Low-dose CT coronary angiography for assessment of coronary artery disease in patients with type 2 diabetes - A cross-sectional study | |
| Arne Borthne3  Odd Erik Johansen4  Lars Gullestad3  Knut Endresen1  Anne Pernille Ofstad4  Geir Reinvik Ulimoen2  | |
| [1] Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, 0372, Norway;Department of Radiology, Akershus University Hospital, Lorenskog, 1478, Norway;University of Oslo, Oslo, Norway;Department of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, Drammen, 3004, Norway | |
| 关键词: Risk assessment; Coronary artery calcification; CT angiography; Imaging; Cardiovascular complications; Type 2 diabetes mellitus; | |
| Others : 1234496 DOI : 10.1186/s12872-015-0143-9 |
|
| received in 2015-07-20, accepted in 2015-11-06, 发布年份 2015 | |
PDF
|
|
【 摘 要 】
Background
Silent coronary artery disease (CAD) is prevalent in type 2 diabetes mellitus (T2DM). Although coronary computed tomography angiography (CCTA) over recent years has emerged a useful tool for assessing and diagnosing CAD it’s role and applicability for patients with T2DM is still unclarified, in particular in asymptomatic patients. We aimed to assess the role of CCTA in detecting and characterizing CAD in patients with T2DM without cardiac symptoms when compared to gold standard invasive coronary angiography (ICA).
Methods
This was a cross-sectional analysis of patients with T2DM without symptomatic CAD enrolled in the Asker and Baerum Cardiovascular Diabetes Study who, following clinical examination and laboratory assessment, underwent subsequently CCTA and ICA.
Results
In total 48 Caucasian patients with T2DM (36 men, age 64.0 ± 7.3 years, diabetes duration 14.6 ± 6.4 years, HbA1c 7.4 ± 1.1 %, BMI 29.6 ± 4.3 kg/m 2 ) consented to, and underwent, both procedures (CCTA and ICA). The population was at intermediate cardiovascular risk (mean coronary artery calcium score 269, 75 % treated with antihypertensive therapy). ICA identified a prevalence of silent CAD at 17 % whereas CCTA 35 %. CCTA had a high sensitivity (100 %) and a high negative predictive value (100 %) for detection of patients with CAD when compared to ICA, but the positive predictive value was low (47 %).
Conclusions
Low-dose CCTA is a reliable method for detection and exclusion of significant CAD in T2DM and thus may be a useful tool for the clinicians. However, a low positive predictive value may limit its usefulness as a screening tool for all CAD asymptomatic patients with T2DM. Further studies should assess the applicability for risk assessment beyond the evaluation of the vascular bed.
【 授权许可】
2015 Ulimoen et al.
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 20151202020244164.pdf | 398KB |
【 参考文献 】
- [1]IDF Diabetes Atlas. In., 6th edn. Brussels, Belgium:International Diabetes Federation; 2013. Available from:. www.idf.org/diabetesatlas
- [2]Lorber D: Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes 2014, 7:169-83.
- [3]Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993, 16(2):434-44.
- [4]Johansen OE, Birkeland KI, Orvik E, Flesland O, Wergeland R, Ueland T, Smith C, Endresen K, Aukrust P, Gullestad L: Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects. Scand J Clin Lab Invest 2007, 67(3):306-16.
- [5]Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, et al.: Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004, 27(8):1954-61.
- [6]Upchurch CT, Barrett EJ: Clinical review: Screening for coronary artery disease in type 2 diabetes. J Clin Endocrinol Metab 2012, 97(5):1434-42.
- [7]Janne d'Othee B, Siebert U, Cury R, Jadvar H, Dunn EJ, Hoffmann U: A systematic review on diagnostic accuracy of CT-based detection of significant coronary artery disease. Eur J Radiol 2008, 65(3):449-61.
- [8]Cademartiri F, Seitun S, Romano M, Maffei E, Fusaro M, Palumbo A, Aldrovandi A, Messalli G, Tresoldi S, Malago R, et al.: Prognostic value of 64-slice coronary angiography in diabetes mellitus patients with known or suspected coronary artery disease compared with a nondiabetic population. Radiol Med 2008, 113(5):627-43.
- [9]Van Werkhoven JM, Cademartiri F, Seitun S, Maffei E, Palumbo A, Martini C, Tarantini G, Kroft LJ, de Roos A, Weustink AC, et al.: Diabetes: prognostic value of CT coronary angiography--comparison with a nondiabetic population. Radiology 2010, 256(1):83-92.
- [10]Andreini D, Pontone G, Bartorelli AL, Agostoni P, Mushtaq S, Antonioli L, Cortinovis S, Canestrari M, Annoni A, Ballerini G, et al.: Comparison of the diagnostic performance of 64-slice computed tomography coronary angiography in diabetic and non-diabetic patients with suspected coronary artery disease. Cardiovasc Diabetol 2010, 9:80. BioMed Central Full Text
- [11]Taylor AJ, Cerqueira M, Hodgson JM, Mark D, Min J, O'Gara P, Rubin GD, Kramer CM, Berman D, Brown A, et al.: ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol 2010, 56(22):1864-94.
- [12]Johansen OE, Gullestad L, Blaasaas KG, Orvik E, Birkeland KI: Effects of structured hospital-based care compared with standard care for Type 2 diabetes-The Asker and Baerum Cardiovascular Diabetes Study, a randomized trial. Diabet. Med. 2007, 24(9):1019-27.
- [13]Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O'Rourke RA, et al.: ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999, 33(7):2092-197.
- [14]World Health Organization: Definition, diagnosis and classification of diabetes mellitus and its complications - Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Geneva; 1999.
- [15]Halliburton SS, Abbara S, Chen MY, Gentry R, Mahesh M, Raff GL, Shaw LJ, Hausleiter J: SCCT guidelines on radiation dose and dose-optimization strategies in cardiovascular CT. J Cardiovasc Comput Tomogr 2011, 5(4):198-224.
- [16]Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15(4):827-32.
- [17]Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB: A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975, 51(4 Suppl):5-40.
- [18]Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977, 33(1):159-74.
- [19]Youssef G, Budoff MJ: Coronary artery calcium scoring, what is answered and what questions remain. Cardiovasc. Diagn Ther 2012, 2(2):94-105.
- [20]Hou Y, Yue Y, Guo W, Feng G, Yu T, Li G, Vembar M, Olszewski ME, Guo Q: Prospectively versus retrospectively ECG-gated 256-slice coronary CT angiography: image quality and radiation dose over expanded heart rates. Int J Cardiovasc Imaging 2012, 28(1):153-62.
- [21]Carrascosa P, Rodriguez-Granillo GA, Capunay C, Deviggiano A: Low-dose CT coronary angiography using iterative reconstruction with a 256-slice CT scanner. World J. Cardiol. 2013, 5(10):382-6.
- [22]Hou Y, Ma Y, Fan W, Wang Y, Yu M, Vembar M, et al. Diagnostic accuracy of low-dose 256-slice multi-detector coronary CT angiography using iterative reconstruction in patients with suspected coronary artery disease. Eur. Radiol. 2014;24(1):3-11.
- [23]Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, Lauer MS, Post WS, Raggi P, Redberg RF, et al.: ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2007, 49(3):378-402.
- [24]Jiang B, Wang J, Lv X, Cai W: Dual-source CT versus single-source 64-section CT angiography for coronary artery disease: A meta-analysis. Clin Radiol 2014, 69(8):861-9.
- [25]Maffei E, Seitun S, Nieman K, Martini C, Guaricci AI, Tedeschi C, Weustink AC, Mollet NR, Berti E, Grilli R, et al.: Assessment of coronary artery disease and calcified coronary plaque burden by computed tomography in patients with and without diabetes mellitus. Eur Radiol 2011, 21(5):944-53.
- [26]Leber AW, Knez A, von Ziegler F, Becker A, Nikolaou K, Paul S, Wintersperger B, Reiser M, Becker CR, Steinbeck G, et al.: Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol 2005, 46(1):147-54.
- [27]Mosseri M, Nahir M, Rozenman Y, Lotan C, Admon D, Raz I, Gotsman MS: Diffuse narrowing of coronary arteries in diabetic patients: the earliest phase of coronary artery disease. Cardiology 1998, 89(2):103-10.
- [28]Elezi S, Kastrati A, Pache J, Wehinger A, Hadamitzky M, Dirschinger J, Neumann FJ, Schomig A: Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998, 32(7):1866-73.
- [29]D'Ascenzo F, Cerrato E, Biondi-Zoccai G, Omede P, Sciuto F, Presutti DG, Quadri G, Raff GL, Goldstein JA, Litt H, et al.: Coronary computed tomographic angiography for detection of coronary artery disease in patients presenting to the emergency department with chest pain: a meta-analysis of randomized clinical trials. Eur Heart J. Card. Imaging 2013, 14(8):782-9.
- [30]Muhlestein JB, Lappe DL, Lima JA, Rosen BD, May HT, Knight S, Bluemke DA, Towner SR, Le V, Bair TL, et al.: Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. JAMA 2014, 312(21):2234-43.
- [31]Wiersma JJ, Verberne HJ, ten Holt WL, Radder IM, Dijksman LM, van Eck-Smit BL, Trip MD, Tijssen JG, Piek JJ: Prognostic value of myocardial perfusion scintigraphy in type 2 diabetic patients with mild, stable angina pectoris. J. Nucl. Cardiol. 2009, 16(4):524-32.
- [32]George RT, Mehra VC, Chen MY, Kitagawa K, Arbab-Zadeh A, Miller JM, Matheson MB, Vavere AL, Kofoed KF, Rochitte CE, et al.: Myocardial CT perfusion imaging and SPECT for the diagnosis of coronary artery disease: a head-to-head comparison from the CORE320 multicenter diagnostic performance study. Radiology 2014, 272(2):407-16.
- [33]Magalhaes TA, Kishi S, George RT, Arbab-Zadeh A, Vavere AL, Cox C, Matheson MB, Miller JM, Brinker J, Di Carli M, et al.: Combined coronary angiography and myocardial perfusion by computed tomography in the identification of flow-limiting stenosis - The CORE320 study: An integrated analysis of CT coronary angiography and myocardial perfusion. J Cardiovasc Comput Tomogr 2015, 9(5):438-45.
- [34]Ofstad AP, Gullestad L, Orvik E, Aakhus S, Endresen K, Ueland T, Aukrust P, Fagerland MW, Birkeland KI, Johansen OE: Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Baerum Cardiovascular Diabetes (ABCD) cohort study. Cardiovasc Diabetol 2013, 12:126. BioMed Central Full Text
PDF